Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Junevity develops therapeutics that aim to restore youthful cellular function and extend healthspan by resetting age-altered transcriptional programs. The company uses its RESET Platform — combining…

Junevity develops therapeutics that aim to restore youthful cellular function and extend healthspan by resetting age-altered transcriptional programs. The company uses its RESET Platform — combining…
Founded: 2023 (out of UCSF)
Headquarters: San Francisco, CA
Tech / Modality: siRNA-based cell reprogramming (RESET platform)
Lead program focus: Metabolic disease (JUN_01) and neurodegeneration
Seed funding: $20M total seed (expanded from $10M)
Age-related diseases and loss of youthful cellular transcriptional programs (e.g., Type 2 Diabetes, Obesity, Osteoarthritis, Sarcopenia, neurodegeneration).
2023
Biotechnology
$10,000,000
Initial seed announced Feb 13, 2025.
$10,000,000
Expanded seed financing announced Dec 3, 2025, bringing total to $20M.
“Investors include venture firms (Goldcrest Capital, Godfrey Capital) alongside biotech veterans, physicians, tech entrepreneurs and hedge fund managers”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
300+
New This Week